Pravastatin sodium is a statin used for specified cholesterol disorders and cardiovascular-risk reduction. The sodium suffix identifies the ingredient salt; it does not describe a dietary sodium treatment or make its strengths equivalent to another statin.
The approved uses and formulations described here follow US prescribing information. They may differ in other countries.
| Medicine detail | Details |
|---|---|
| Active ingredient(s) | pravastatin sodium |
| Medicine class | HMG-CoA reductase inhibitor (statin) |
| Forms and strengths | Oral tablets; the cited prescribing information lists 10, 20, 40 and 80 mg; individual supplied products may cover fewer strengths |
Uses extend beyond a cholesterol number
The cited US label includes selected cardiovascular-risk reductions in adults, LDL lowering in primary hyperlipidemia and heterozygous familial hypercholesterolemia from age 8, plus adult hypertriglyceridemia and primary dysbetalipoproteinemia. The specific condition and clinical history determine whether a labeled use applies.
Source: [1]
Read the supplied product's strength
The prescribing information lists 10, 20, 40 and 80 mg tablets, but the linked repackaged product does not establish supply of every strength. Check the actual manufacturer's pack and directions. Pravastatin is taken once daily; kidney impairment and interacting medicines can change the prescribed regimen.
Source: [1]
Muscle and liver precautions remain relevant
Pravastatin can cause myopathy, rhabdomyolysis and rare immune-mediated necrotizing myopathy. Report unexplained muscle pain, tenderness or weakness promptly, especially with fever or malaise. Acute liver failure and decompensated cirrhosis are contraindications. Liver enzymes may be checked before treatment and as clinically indicated.
Source: [1]
Interactions and reproductive advice
Cyclosporine, certain antibiotics, fibrates and other products require an interaction review. Discuss pregnancy as soon as it is recognized: treatment is generally stopped, with any exceptional need assessed individually. Breastfeeding is not recommended during treatment. These issues should be reviewed for pravastatin itself rather than assumed from another statin.
Source: [1]
Review the response before changing medicines
The clinician uses LDL measurements and cardiovascular history to assess response. The label discusses choosing alternative LDL-lowering treatment when higher-intensity treatment is required or the response is insufficient. That is a prescribing decision, not a reason to double tablets or add another statin independently.
The Pravastatin and Lipitor comparison provides a separate side-by-side reference, without establishing an individual treatment choice.
Source: [1]
Questions and answers
Why is sodium part of pravastatin's name?
It identifies the drug's salt form. It does not mean the tablet is prescribed as sodium replacement.
Does the cited listing prove all strengths are locally stocked?
No. Prescribing information and a repackaged listing do not prove local supply or every manufacturer's presentation.
Is pravastatin free of muscle warnings?
No. Its own label includes myopathy and rhabdomyolysis warnings and advice to report unexplained muscle symptoms.
Related reading
Sources
Sources checked 27 October 2026. This information does not replace advice from your healthcare professional. For complete warnings and instructions, read the product information and consult the prescribing team.
Reviewed by: Mattias Hagman, PhD
About the reviewer:
Dr Mattias Hagman (PhD, University of Sydney) has an academic background and experience working with healthcare-related content and regulated industries. He has lecturing experience at international universities, including Stockholm University and the University of Malta.
Last reviewed: October 2026